Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

AstraZeneca
Harvard Business School
Merck
McKesson
Dow
Boehringer Ingelheim

Last Updated: December 11, 2019

DrugPatentWatch Database Preview

Litigation Details for Bayer Schering Pharma AG v. Sandoz, Inc. (S.D.N.Y. 2008)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Bayer Schering Pharma AG v. Sandoz, Inc. (S.D.N.Y. 2008)

Docket   Start Trial Date Filed 2008-04-18
Court District Court, S.D. New York Date Terminated 2012-08-27
Cause 28:1331 Fed. Question: Other Assigned To Paul G. Gardephe
Jury Demand Plaintiff Referred To Magistrate Judge James C. Fran
Parties BAYER HEALTHCARE PHARMACEUTICALS, INC.; BAYER SCHERING PHARMA AG; SANDOZ, INC.; WATSON LABORATORIES, INC.; WATSON PHARMACEUTICALS, INC.
Patents 5,569,652; 6,787,531; 6,933,395
Attorneys Adam K. Mortara; Bradford J. Badke; Byron R. Chin; Cedric Chia Yang Tan; Delphine Knight Brown; Jeanne C. Curtis; Jonathan J. Anastasia; Joseph A. Hynds; Kevin D. McDonald; Kristen Marie Cooklin; Lisa N. Phillips; Mark T. Jansen; Matthew A. Traupman; Matthew Raymond Ford; Nancy Lynn Tompkins; Paul J. Skiermont; Paul Wendell Garrity; Peter Benjamin Bensinger , Jr.; Phillip A. Proger; Ronald William Meister; Steven Jerome Moore; Steven M Lieberman; Thomas Kjellberg
Link to Docket External link to docket
Small Molecule Drugs cited in Bayer Schering Pharma AG v. Sandoz, Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial , and   Start Trial .

Details for Bayer Schering Pharma AG v. Sandoz, Inc. (S.D.N.Y. 2008)

Date Filed Document No. Description Snippet Link To Document
2008-04-18 1 Complaint thereto. PATENT-IN-SUIT 20. The patent-in-suit is United States Patent No. 5,569,652 (“the ‘652 patent”) (… Unith StateS Patent [19] [11] Patent Number: 5,569,652 Beier et al. [45] Date of Patent: Oct. 29, 1996… CoUNT ONE: CLAIM FoR PATENT INFRINGEMENT OF UNITED STATES PATENT No. 5,569,652 AGAINST SANDoz, INC. UNDER… CoUNT Two: CLAIM FoR PATENT INFRINGEMENT OF UNITED STATES PATENT No. 5,569,652 AGAINST SANDoz, INC. UNDER…CoUNT THREE: CLAIM FoR PATENT INFRINGEMENT OF UNITED STATES PATENT No. 5,569,652 AGAINsT WATsoN UNDER 35 External link to document
2010-02-04 113 Claim for Infringement of United States Patent No.5,569,652. Supplemental Request for Judicial NOtice… 27 August 2012 1:08-cv-03710-PGG-JCF Patent Plaintiff District Court, S.D External link to document
2010-09-02 160 U.S. Patent No. 6,787, 531 (“the ‘531 patent”), U.S. Reissue Patent No. 37,564 (“the ‘564 patent”), and… the patent has expired; (III) the patent is set to expire on a certain date; or (IV) the patent is invalid… and U.S. Reissue Patent No. 37, 838 (“the ‘838 patent”), all relating to Yaz. (Jansen Decl. ¶ 3, Id.… York for infringement of U.S. Patent No. 5,569,652 (“the ‘652 patent”) in connection with Yasmin. (Cmplt…Nevada alleging infringement of the ‘564 patent and the ‘838 patent in connection with Yaz. (Jansen Decl External link to document
2008-09-26 26 Non-Liability As To Defendant Sandoz and U.S. Patent Number 6,933,395. Document filed by Bayer Schering Pharma… 27 August 2012 1:08-cv-03710-PGG-JCF Patent Plaintiff District Court, S.D External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Moodys
Boehringer Ingelheim
Express Scripts
McKesson
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.